newsfilter
← Latest News
Business Wire·

PharmaCyte Biotech Announces Final Results of Tender Offer

PharmaCyte Biotech, Inc. (NASDAQ:PMCB) ("PharmaCyte" or the "Company") today announces the final results of its previously announced tender offer to acquire up to 7,750,000 million shares of the Company's common stock,